BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Historical Holders from Q3 2023 to Q3 2025

Symbol
DRUG on Nasdaq
CUSIP
10919W405
Type / Class
Equity / Common Stock, no par value
Shares outstanding
7.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
6.03M
Holdings value
$366M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
62
Number of buys
37
Number of sells
-14
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 16.3% +1.88% $48.9M $1.46M 1.15M +3.09% JANUS HENDERSON GROUP PLC Jun 30, 2025
COMMODORE CAPITAL LP 7.2% $18M 500K COMMODORE CAPITAL LP Dec 31, 2024
Vivo Opportunity Fund Holdings, L.P. 6.4% $27.6M 454K Vivo Opportunity Fund Holdings, L.P. Sep 30, 2025
PERCEPTIVE ADVISORS LLC 6.3% $16M 445K Perceptive Advisors LLC Mar 31, 2025
Adage Capital Management, L.P. 5.58% $24M 396K Adage Capital Management, L.P. Sep 30, 2025
RA CAPITAL MANAGEMENT, L.P. 2.9% $7.45M 206K RA Capital Management, L.P. Mar 31, 2025
Sio Capital Management, LLC 2.69% -65.4% $11.6M -$19.5M 191K -62.8% Sio Capital Management, LLC Sep 30, 2025
Point72 Asset Management, L.P. 3% $4.88M 135K Point72 Asset Management, L.P. Dec 31, 2024

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 6.03M $366M +$48.6M $60.66 62
2025 Q2 5.24M $137M -$2.44M $26.11 47
2025 Q1 5.22M $188M +$11.6M $36.07 34
2024 Q4 4.9M $176M +$167M $36.02 30
2024 Q3 192K $230K -$6.16K $1.17 6
2024 Q2 197K $207K -$19.3K $1.05 5
2024 Q1 213K $256K -$27.2K $1.20 7
2023 Q4 228K $330K +$48.2K $1.43 6
2023 Q3 195K $309K +$309K $1.60 5